Category Archives: Result Analysis

Sun Pharmaceutical Industries Ltd (SUNPHARMA) – Q1 FY2026-27 Results Analysis

By | July 31, 2026 10:34 am

Executive Summary: The Headline Solid top-line and reported profit growth: Revenue +10.5% YoY to ₹15,300 Cr. Reported PAT +27% YoY to ₹2,895 Cr. Adjusted PAT +3.1% to ₹3,089 Cr. India and Specialty drove performance: India Formulations grew 16% YoY. Global Innovative Medicines grew 12.8%. US Formulations declined. Overarching narrative: A steady quarter for India’s largest… Read More »

GAIL (India) Ltd – Q1 FY2026-27 Results Analysis

By | July 31, 2026 9:27 am

Executive Summary: The Headline Exceptional profitability surge: Consolidated PAT nearly doubled (+97% YoY) to ₹4,665–4,671 Cr. Revenue +17% YoY to ₹41,350 Cr. Gas Marketing drove the beat: Natural Gas Marketing PBIT more than tripled, becoming the primary earnings engine. Transmission remained stable, while Petrochemicals stayed weak. Overarching narrative: A strong quarter for GAIL, powered by… Read More »

Asian Paints Ltd (ASIANPAINT) – Q1 FY2026-27 Results Analysis

By | July 29, 2026 6:02 pm

Executive Summary: The Headline Strong double-digit growth with margin expansion: Revenue +17.9% YoY to ₹10,542 Cr. PAT +40% YoY to ₹1,539 Cr. EBITDA +33.5% YoY to ₹2,169 Cr. Healthy volume-led recovery: Decorative paints (India) volume +9%, value +16.6%. Industrial coatings +16%+ value growth. International business +27.2% (INR terms). Overarching narrative: An excellent start to FY27.… Read More »

Jindal Steel Ltd (JINDALSTEL) – Q1 FY2026-27 Results Analysis

By | July 25, 2026 12:05 pm

Executive Summary: The Headline Strong top-line, sharp profit decline: Revenue +25.9% YoY to ₹15,482 Cr. Consolidated PAT –43.6% YoY to ₹844 Cr. Adjusted EBITDA –11.5% YoY to ₹2,667 Cr. Margin compression: EBITDA margin fell to 17.18% (from ~24.4% YoY) due to higher coking coal costs and other expenses. Overarching narrative: A mixed quarter. Robust volume… Read More »

Steel Authority of India Ltd (SAIL) – Q1 FY2026-27 Results Analysis

By | July 25, 2026 11:59 am

Executive Summary: The Headline Sharp profit surge: Standalone PAT +138% YoY to ₹1,636 Cr. Consolidated PAT +121% YoY to ₹1,644 Cr. Strong margin expansion: EBITDA +49% YoY to ₹4,356 Cr. Operating margin expanded to 16.60% (from ~11.3% YoY). Overarching narrative: A strong profitability-driven quarter for SAIL. Revenue was largely flat (+1.25% YoY to ₹26,246 Cr)… Read More »

Vishal Mega Mart Limited (VMM) Results Analysis

By | July 24, 2026 3:23 pm

Vishal Mega Mart Limited (VMM) delivered a strong fundamental performance for Q1 FY2026-27, highlighted by robust double-digit growth in both the top and bottom lines, despite inflationary headwinds in the value retail sector. The 3-Bullet Summary Strong Profit & Revenue Growth: Consolidated net profit surged 25.6% YoY to ₹258.77 crore, while revenue from operations climbed… Read More »

Adani Power Limited (ADANIPOWER) Results Analysis

By | July 22, 2026 5:34 pm

Adani Power Limited (ADANIPOWER) delivered an all-time record performance for Q1 FY2026-27 (quarter ended June 30, 2026), comfortably surpassing consensus street estimates across all key operational and financial metrics. The 3-Bullet Summary Massive Top-Line & Bottom-Line Growth: Revenue from operations surged 33.97% YoY to ₹18,901.89 Cr, while Consolidated Net Profit (PAT) jumped 47.24% YoY to… Read More »

Dr. Reddy’s Laboratories Ltd (DRREDDY) – Q1 FY2026-27 Results Analysis

By | July 22, 2026 5:30 pm

Executive Summary: The Headline Weak headline numbers due to known headwinds: Revenue ₹8,071 Cr (–5.6% YoY). PAT ₹444 Cr (–69% YoY). EBITDA ₹1,009 Cr (–56% YoY). EBITDA margin compressed sharply to 12.5% (vs 26.7% YoY). Key impacts: Lower Lenalidomide sales in North America and a one-time ₹240 Cr provision related to Semaglutide API quality issue.… Read More »

Nestlé India Ltd (NESTLEIND) – Q1 FY2026-27 Results Analysis

By | July 22, 2026 5:17 pm

Executive Summary: The Headline Exceptional growth with strong margin expansion: Revenue +25.2% YoY to ₹6,378 Cr. PAT +48% YoY to ₹975 Cr. EBITDA +40% YoY to ₹1,538 Cr. Volume-led outperformance: Double-digit volume growth across categories, supported by premiumisation and brand investments. Overarching narrative: A powerful quarter signalling a clear recovery in FMCG demand. Nestlé delivered… Read More »